RESEARCH TRIANGLE PARK, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore visi ...
XDA Developers on MSN
This self-hosted presentation tool does everything Canva does, and it costs nothing
Paying for Canva Pro isn't necessary ...
Five student projects showcase how data analysis geared at answering the right questions creates opportunities and impact for ...
CAMBRIDGE, MA / / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results